Supplements Exposed: What Really Works for Prostate Health

DrTalks

G. Espinosa

Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Early Detection of Lung Cancer Using Low-Dose CT Scanning

University Hospitals

G. Rao, A. Gupta, L. Whalen

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Prostate Cancer Detection: MRI, Image Quality, and PI-RADS Techniques

International Cancer Imaging Society (ICIS)

P. Asbach

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

Imaging for Neuroendocrine Neoplasms

North American Neuroendocrine Tumor Society

G. Spilberg

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

Urologic Oncology: What to Look for in 2025

GWU Urology

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

Breast Imaging and the Young Patient

Cleveland Clinic Taussig Cancer Institute

L. Dean

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

GnRH Agonists vs. Antagonists in Prostate Cancer

Patrick Campbell